Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
Clinical trial NCT07537088 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07537088
- Sponsor
- First Affiliated Hospital of Wannan Medical College
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2027-04-01
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.